Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial.
Lancet Gastroenterol Hepatol. 2022 Mar;7(3):219-229. doi: 10.1016/S2468-1253(21)00385-X. Epub 2022 Jan 20.
Lancet Gastroenterol Hepatol. 2022.
PMID: 35065058
Free PMC article.
Clinical Trial.
Neoadjuvant immunotherapy for resectable hepatocellular carcinoma - Authors' reply.
Marron TU, Schwartz ME, Miller E, Thanigaimani P, Lowy I, Thurston G, Merad M.
Marron TU, et al. Among authors: thanigaimani p.
Lancet Gastroenterol Hepatol. 2022 Jun;7(6):505. doi: 10.1016/S2468-1253(22)00122-4.
Lancet Gastroenterol Hepatol. 2022.
PMID: 35550051
No abstract available.
Item in Clipboard
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Xiao J, Hooper AT, Hamilton JD, Musser BJ, Rofail D, Hussein M, Im J, Atmodjo DY, Perry C, Pan C, Mahmood A, Hosain R, Davis JD, Turner KC, Baum A, Kyratsous CA, Kim Y, Cook A, Kampman W, Roque-Guerrero L, Acloque G, Aazami H, Cannon K, Simón-Campos JA, Bocchini JA, Kowal B, DiCioccio AT, Soo Y, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD; Trial Investigators.
Weinreich DM, et al.
N Engl J Med. 2021 Dec 2;385(23):e81. doi: 10.1056/NEJMoa2108163. Epub 2021 Sep 29.
N Engl J Med. 2021.
PMID: 34587383
Free PMC article.
Clinical Trial.
Item in Clipboard
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study.
Hsu C, Lee SH, Ejadi S, Even C, Cohen RB, Le Tourneau C, Mehnert JM, Algazi A, van Brummelen EMJ, Saraf S, Thanigaimani P, Cheng JD, Hansen AR.
Hsu C, et al. Among authors: thanigaimani p.
J Clin Oncol. 2017 Dec 20;35(36):4050-4056. doi: 10.1200/JCO.2017.73.3675. Epub 2017 Aug 24.
J Clin Oncol. 2017.
PMID: 28837405
Clinical Trial.
Item in Clipboard
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer.
Mehnert JM, Varga A, Brose MS, Aggarwal RR, Lin CC, Prawira A, de Braud F, Tamura K, Doi T, Piha-Paul SA, Gilbert J, Saraf S, Thanigaimani P, Cheng JD, Keam B.
Mehnert JM, et al. Among authors: thanigaimani p.
BMC Cancer. 2019 Mar 4;19(1):196. doi: 10.1186/s12885-019-5380-3.
BMC Cancer. 2019.
PMID: 30832606
Free PMC article.
Clinical Trial.
Item in Clipboard
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study.
Cohen RB, Delord JP, Doi T, Piha-Paul SA, Liu SV, Gilbert J, Algazi AP, Damian S, Hong RL, Le Tourneau C, Day D, Varga A, Elez E, Wallmark J, Saraf S, Thanigaimani P, Cheng J, Keam B.
Cohen RB, et al. Among authors: thanigaimani p.
Am J Clin Oncol. 2018 Nov;41(11):1083-1088. doi: 10.1097/COC.0000000000000429.
Am J Clin Oncol. 2018.
PMID: 29462123
Free PMC article.
Item in Clipboard
Cite
Cite